Atacand (candesartan) Real Life Study - Real Life

Study identifier:NIS-CSE-ATA-2008/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A REtrospective study on the effects of cAndesartan vs. Losartan on blood pressure, health care consumption and cardiovascuLar events In a "real-liFe" GP sEtting in Sweden

Medical condition

hypertension

Phase

-

Healthy volunteers

No

Study drug

Candesartan Cilexetil, Losartan

Sex

All

Actual Enrollment

14000

Study type

Observational

Age

17 Years +

Date

Study Start Date: 01 Mar 2008
Primary Completion Date: 01 Feb 2009
Study Completion Date: 01 Feb 2009

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria